Work

P02.317 Olanzapine versus risperidone: A prospective comparison of clinical and economic outcomes in schizophrenia

Year: 2000

Type: conference-abstract

Source: European Psychiatry

DOI: 10.1016/s0924-9338(00)94724-2

Authors: E.T. Edgell, W.Scott Andersen, B.M. Johnstone, B. Dulisse, D. Revicki, A. Breier, S. Gavart

Institution: Eli Lilly (United States)

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W1975524201

Cites:

Cited by: 4

Related to: 10